GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Tr… (NCT02872987) | Clinical Trial Compass
RecruitingNot Applicable
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
The GMALL registry serves the purpose of ALL research and quality assurance. The Registry collects data about diagnostics, treatment and outcome of Adult ALL Patients in the clinical routine, whether or not the patient is treated within a clinical trial.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Acute Lymphoblastic Leukemia (All Subtypes) if treated according to ALL protocols
* Other Types of Leukemia (NK Cell Lymphoma/Leukemia, Biphenotypic Acute Leukemia) if treated according to ALL protocols
* Non-Hodgkin's Lymphoma of Following Subtypes: Burkitt Lymphoma, B Cell Lymphoma, B- or T-lineage Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, Other NHL) if treated according to B-ALL protocols
* Age minimum 18 yrs
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this is a registry study rather than a treatment trial, does participating in it change anything about the actual treatment I would receive for my ALL, or does it only involve sharing my data and biological samples?
2This registry is collecting information on diagnosis, treatment, and outcomes — including overall survival — for ALL patients over time, so could my doctor explain how the data collected here might eventually benefit future patients, and what it means for me personally right now?
3Because this is a biomaterial collection study, what kinds of biological samples would I need to provide, how often, and are there any risks or burdens associated with giving those samples that I should weigh against participating?
4Given that this registry is run through GMALL, a German leukemia study group, is my care center actively affiliated with this network, and does participating ensure my treatment follows their established ALL protocols or guidelines?
5Would joining this registry have any impact on my eligibility for other clinical trials that might offer me access to new treatments, or can I do both at the same time?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.